PALATIN TECHNOLOGIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.95 USD | +2.63% |
|
+3.17% | -51.01% |
Chart calendar Palatin Technologies, Inc.
5c7bf60e1b4.qndfUp_-LkxceTjPBgw3U_Z58bcR4oURIfOw5sfMugc.4CMrH9LPQH0NCne1MjoDYJ5OnPxgiLFyfrHTiuq4-1PLOB5g1YRhCjosYQ~672c9184bc408caec2dd5970cec88ee2
Upcoming events on Palatin Technologies, Inc.
Past events on Palatin Technologies, Inc.
| 26/06/2024 | Annual General Meeting |
| 15/05/2024 16:00 | Q3 2024 Earnings Call |
| 15/05/2024 12:30 | Q3 2024 Earnings Release |
| 08/05/2024 15:00 | Investor Meeting - Key Opinion Leader |
| 19/04/2024 02:01 | Q4 2023 Earnings Release |
| 28/02/2024 13:30 | PL9643 MELODY-1 Phase 3 Clinical Study Results Call |
| 15/02/2024 16:00 | Q2 2024 Earnings Call |
| 15/02/2024 12:30 | Q2 2024 Earnings Release |
| 14/11/2023 16:00 | Q1 2024 Earnings Call |
| 14/11/2023 12:30 | Q1 2024 Earnings Release |
| 13/10/2023 | United European Gastroenterology Week Conference |
| 28/09/2023 16:00 | Q4 2023 Earnings Call |
| 28/09/2023 12:30 | Q4 2023 Earnings Release |
| 13/09/2023 15:00 | H.C. Wainwright Global Investment Conference |
| 09/08/2023 22:00 | Canaccord Genuity Growth Conference |
| 20/06/2023 14:00 | Annual General Meeting |
| 16/05/2023 16:00 | Q3 2023 Earnings Call |
| 16/05/2023 12:30 | Q3 2023 Earnings Release |
| 08/05/2023 16:00 | Investor Meeting - Key Opinion Leader |
| 05/05/2023 | Digestive Disease Week |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,3 0,00 - | 0,12 0,11 5.35% | -0,19 0,27 -169.42% | 1,47 0,92 59.67% | 4,85 4,47 8.7% | 4,13 |
|
EBITDA Million USD | Released Forecast Spread | 35,8 -22,4 259.83% | -23,5 -22,4 -5.1% | -33,3 -28,8 -15.74% | 0,00 0,00 - | -32,2 -30,1 -6.88% | -43,0 |
|
EBIT Million USD | Released Forecast Spread | 35,7 -22,0 262.2% | -23,6 -22,1 -6.79% | -33,4 -27,3 -22.4% | -36,6 -32,0 -14.45% | -32,5 -29,3 -10.95% | -23,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 35,8 -22,2 261.49% | -22,4 -20,7 -8.32% | -33,6 -27,1 -23.94% | -36,2 -31,9 -13.63% | -32,2 -28,7 -12.31% | -34,8 |
|
Net income Million USD | Released Forecast Spread | 35,8 -22,2 261.49% | -22,4 -20,7 -8.32% | -33,6 -27,1 -23.94% | -36,2 -31,9 -13.63% | -27,5 -23,3 -18.07% | -34,6 |
|
EPS USD | Released Forecast Spread | 4,00 -2,67 250% | -2,50 -2,25 -11.11% | -3,50 -2,83 -23.53% | -3,79 -3,27 -15.78% | -2,53 -2,12 -19.34% | -2,31 |
| Announcement Date | 12/09/19 | 25/09/20 | 28/09/21 | 22/09/22 | 28/09/23 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,22 0,35 -37.54% | 0,77 0,22 248.75% | 0,87 0,79 10.71% | 1,03 1,61 -36.41% | 1,20 1,11 7.77% | 1,76 1,36 29.78% | 2,11 5,68 -62.91% | 2,03 6,29 -67.67% | 0,00 0,08 - | 0,00 | 0,00 | 0,00 | 0,00 | 7,50 |
|
EBITDA Million USD | Released Forecast Spread | -7,78 -8,50 8.51% | -8,69 -13,0 33.13% | -6,54 -8,90 26.47% | -7,22 -6,80 -6.23% | -10,7 -7,40 -45.1% | -6,02 -8,90 32.34% | 1,26 -6,40 119.65% | -9,13 -10,7 14.64% | -10,3 | |||||
|
EBIT Million USD | Released Forecast Spread | -7,82 -8,95 12.62% | -13,1 -8,48 -54.55% | -8,75 -10,2 14.13% | -6,61 -7,76 14.82% | -7,30 -8,27 11.67% | -10,8 -7,26 -48.98% | -6,11 -1,10 -457.38% | 1,17 -0,31 476.01% | -9,22 -8,23 -12.03% | -9,37 | -9,73 | -10,4 | -11,1 | -4,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,63 -8,73 12.54% | -12,8 -8,40 -51.95% | -8,26 -11,5 28.45% | -6,10 -8,08 24.54% | -7,15 -7,39 3.3% | -10,7 -7,18 -49.14% | -5,89 -4,86 -21.25% | -7,84 -2,17 -261.14% | -8,44 -8,98 6.03% | -9,69 | -9,61 | -10,3 | -11,0 | -4,27 |
|
Net income Million USD | Released Forecast Spread | -7,63 -8,73 12.54% | -12,8 -8,40 -51.95% | -8,26 -11,5 28.45% | -1,42 -7,63 81.34% | -7,15 -7,39 3.3% | -10,7 -6,51 -64.62% | -5,89 -4,86 -21.25% | -7,84 -2,58 -203.95% | -8,44 -8,39 -0.5% | -9,08 | -9,61 | -10,3 | -11,0 | -4,27 |
|
EPS USD | Released Forecast Spread | -0,75 -0,83 10% | -1,34 -0,81 -64.75% | -0,86 -1,20 28.03% | -0,13 -0,70 81.34% | -0,63 -0,53 -20% | -0,91 -0,56 -62.5% | -0,48 -0,41 -17.07% | -0,56 -0,20 -175.41% | -0,53 -0,50 -6.71% | -0,51 | -0,26 | -0,24 | -0,19 | -0,07 |
| Announcement Date | 16/05/22 | 22/09/22 | 14/11/22 | 14/02/23 | 15/05/23 | 28/09/23 | 14/11/23 | 14/02/24 | 15/05/24 | - | - | - | - | - |
More events
Past sector events for Palatin Technologies, Inc.
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PTN Stock
- Calendar Palatin Technologies, Inc.
